Summary
CVS Health Corporation reported revenues of $91.23 billion for the second quarter of 2024, a 2.6% increase year-over-year, primarily driven by growth in its Health Care Benefits and Pharmacy & Consumer Wellness segments. However, net income attributable to CVS Health decreased by 6.9% to $1.77 billion, or $1.41 per diluted share. This decline was largely influenced by increased health care costs, particularly within the Health Care Benefits segment, where the Medical Benefit Ratio (MBR) rose to 89.6% due to higher utilization and the impact of reduced Medicare Advantage star ratings. The Health Services segment experienced an 8.8% revenue decrease due to client losses and pricing pressures, though adjusted operating income saw a slight increase. The company continued its strategic investments, including the integration of Oak Street Health and Signify Health, and actively managed its capital through share repurchases and debt issuance. Looking ahead, CVS Health anticipates continued elevated utilization in Medicare Advantage programs, which is expected to pressure its Health Care Benefits segment and health care delivery assets. The company also faces medical cost pressures in its Medicaid business due to higher acuity following member redeterminations. Despite these challenges, CVS Health expects growth in its newer ventures like Cordavis, Oak Street Health, and Signify Health, and is focused on enterprise-wide cost savings initiatives to improve its operating cost structure. The company maintains a strong liquidity position with $12.5 billion in cash and cash equivalents as of June 30, 2024.
Financial Highlights
54 data points| Revenue | $91.23B |
| Cost of Revenue | $50.00B |
| Gross Profit | $41.24B |
| Operating Expenses | $88.19B |
| Operating Income | $3.04B |
| Net Income | $1.77B |
| EPS (Basic) | $1.41 |
| EPS (Diluted) | $1.41 |
| Shares Outstanding (Basic) | 1.26B |
| Shares Outstanding (Diluted) | 1.26B |
Key Highlights
- 1Total revenues for Q2 2024 increased by 2.6% to $91.23 billion, primarily driven by the Health Care Benefits and Pharmacy & Consumer Wellness segments.
- 2Net income attributable to CVS Health decreased by 6.9% to $1.77 billion ($1.41 per diluted share) due to increased health care costs and the impact of Medicare utilization.
- 3The Medical Benefit Ratio (MBR) in the Health Care Benefits segment increased to 89.6% from 86.2% year-over-year, driven by higher utilization and a negative impact from Medicare Advantage star ratings.
- 4Health Services segment revenues declined by 8.8% to $42.17 billion, impacted by client losses and pricing pressures, although adjusted operating income saw a slight 1.1% increase.
- 5Pharmacy & Consumer Wellness segment revenues grew by 3.7% to $29.84 billion, supported by increased prescription volume, but adjusted operating income decreased by 12.0% due to reimbursement pressures.
- 6CVS Health repurchased $3.0 billion of its common stock during the first six months of 2024, demonstrating a commitment to returning capital to shareholders.
- 7The company ended the quarter with a strong cash position of $12.5 billion, providing flexibility for operations and strategic initiatives.